article thumbnail

Customs and Trade News Weekly Snapshot

Customs & International Trade Law

The FDA issued draft guidance to clarify how the agency evaluates real-world data (RWD) to determine whether they are of sufficient quality for generating real-world evidence (RWE) that can be used in FDA regulatory decision-making for medical devices. This draft guidance also proposes expanded recommendations to the 2017 guidance.

eFiling 52